Sight Sciences, Inc. (SGHT) stock
SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.49−0.10 (-0.94%)
Close on Nov 17, 2026Market cap $577.87MP/E –Yield –
Sight Sciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Sight Sciences's ebitda for the twelve months ending Jun 30, 2026 was -$27.47M. For fiscal 2025 it was -$36.61M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$36.61M | – |
| FY2024 | Dec 31, 2024 | -$49.82M | – |
| FY2023 | Dec 31, 2023 | -$56.66M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.79M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.31M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.56M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.80M | – |
| Q2 FY2025 | Jun 30, 2025 | -$11.54M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.71M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.75M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.07M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.47M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.53M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.95M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.25M | – |
| Q2 FY2023 | Jun 30, 2023 | -$15.04M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.42M | – |
See a number that looks wrong?